000 01212 a2200313 4500
005 20250517040737.0
264 0 _c20160419
008 201604s 0 0 eng d
022 _a1520-5010
024 7 _a10.1021/acs.chemrestox.5b00208
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aVinken, Mathieu
245 0 0 _aAdverse Outcome Pathways and Drug-Induced Liver Injury Testing.
_h[electronic resource]
260 _bChemical research in toxicology
_cJul 2015
300 _a1391-7 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aBosentan
650 0 4 _aChemical and Drug Induced Liver Injury
_xmetabolism
650 0 4 _aCholestasis
_xchemically induced
650 0 4 _aFatty Liver
_xchemically induced
650 0 4 _aHumans
650 0 4 _aLiver Cirrhosis
_xchemically induced
650 0 4 _aMethotrexate
_xtoxicity
650 0 4 _aQuantitative Structure-Activity Relationship
650 0 4 _aSulfonamides
_xtoxicity
650 0 4 _aValproic Acid
_xtoxicity
773 0 _tChemical research in toxicology
_gvol. 28
_gno. 7
_gp. 1391-7
856 4 0 _uhttps://doi.org/10.1021/acs.chemrestox.5b00208
_zAvailable from publisher's website
999 _c25024763
_d25024763